Show menu

Latest news from SEQENS Group

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
image
SEQENS and Novonesis announce strategic partnership for enhancing customer’s access to industrial biocatalytic processes
Read more
image
SEQENS and APPLEXION announce strategic partnership for the distribution of SEQENZYM FT
Read more
image
Smart Immune and CELLforCURE by SEQENS partner to industrialize SMART101 clinical batches manufacturing
Read more
image
Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK
Read more
image
European Industry Summit: Pierre Luzeau, CEO of Seqens joins 73 industry leaders to call for a European Industrial Deal
Read more
image
Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India
Read more
image
Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis
Read more
image
Seqens confirms the acquisition of CELLforCURE
Read more
image
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Read more
image
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
image
Raw materials, energy and transport: rising prices & availability
Read more
image
SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.
Read more
1 2 3